Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heamac Healthcare is an India-based medtech company focused on neonatal care, with a primary emphasis on phototherapy systems for neonatal jaundice management. The company develops and markets device-based solutions for hospitals and home-care settings, including its nLite360 product family and related jaundice-management tools. Its positioning is healthcare delivery and medical technology rather than therapeutics, with a design-driven approach centered on improving newborn outcomes and reducing mother-infant separation during treatment. Heamac appears to be a private, active company founded in 2018 and headquartered in Hyderabad, Telangana. The business is best characterized as a commercial-stage neonatal device company rather than a biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heamac Healthcare.